Clinical Trial Update: Intramyocardial Transplantation of Bone Marrow Stem Cells in Addition to Coronary Artery Bypass Graft (CABG) Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial of intramyocardial bone marrow stem cell transplantation added to CABG was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia

Drugs mentioned

• Bone marrow stem cells

Snippet

Sponsor: Miltenyi Biotec B.V. & Co. KG | Conditions: Myocardial Ischemia, Coronary Artery Disease | Phase 3 | Status: TERMINATED